Alphatec Holdings, Inc. Provides Revenue Guidance for the Year Ended December 31, 2021
January 12, 2021 at 09:00 am EST
Share
Alphatec Holdings, Inc. provided revenue guidance for the year ended December 31, 2021. For the year, the company expects total revenue to approximate $178 million, which includes U.S.revenue of approximately $176 million. Revenue guidance reflects expected U.S.revenue growth of approximately 25% compared to 2020, driven by continued launches of novel procedures and products and growing traction of the procedures and products released in 2020. Total revenue guidance contemplates the anticipated wind-down of the company’s international supply agreement by August 2021. The company expects to update guidance to reflect the positive impact of EOS imaging when that transaction closes, which is anticipated in Second Quarter 2021.
Alphatec Holdings, Inc., through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company. The Company is focused on the design, development, and advancement of technology for surgical treatment of spine disorders. It has a range of product portfolios designed to address the spine's various pathologies. Its AIX product platform comprises of its EOS imaging system and VEA alignment mobile application, its SafeOp Neural InformatiX System and Valence. The EOS imaging system is designed to provide calibrated full-body imaging that enables a three-dimensional (3D) model of patientsâ skeletal systems. It has developed a patient positioning systems that integrates with its other access systems, providing for a more rigid construct and enhanced reproducibility. It offers procedure-specific access systems, including its Sigma-ALIF Access System, which allows for custom anterior abdominal exposure.
ALPHATEC HOLDINGS, INC. 
